Maternal diabetes increases large conductance Ca2+-activated K+ outward currents that alter action potential properties but do not contribute to attenuated excitability of parasympathetic cardiac motoneurons in the nucleus ambiguus of neonatal mice.
Previously, we demonstrated that maternal diabetes reduced the excitability and increased small-conductance Ca(2+)-activated K(+) (SK) currents of parasympathetic cardiac motoneurons (PCMNs) in the nucleus ambiguus (NA). In addition, blockade of SK channels with apamin completely abolished this reduction. In the present study, we examined whether maternal diabetes affects large-conductance Ca(2+)-activated K(+) (BK) channels and whether BK channels contribute to the attenuation of PCMN excitability observed in neonates of diabetic mothers. Neonatal mice from OVE26 diabetic mothers (NMDM) and normal FVB mothers (control) were used. The pericardial sac of neonatal mice at postnatal days 7-9 was injected with the tracer X-rhodamine-5 (and 6)-isothiocyanate 2 days prior to the experiment to retrogradely label PCMNs in the NA. Whole cell current- and voltage-clamps were used to measure spike frequency, action potential (AP) repolarization (half-width), afterhyperpolarization potential (AHP), transient outward currents, and afterhyperpolarization currents (I(AHP)). In whole cell voltage clamp mode, we confirmed that maternal diabetes increased transient outward currents and I(AHP) compared with normal cells. Using BK channel blockers charybdotoxin (CTx) and paxilline, we found that maternal diabetes increased CTx- and paxilline-sensitive transient outward currents but did not change CTx- and paxilline-sensitive I(AHP). In whole cell current-clamp mode, we confirmed that maternal diabetes increased AP half-width and AHP, and reduced excitability of PCMNs. Furthermore, we found that after blockade of BK channels with CTx or paxilline, maternal diabetes induced a greater increase of AP half-width but similarly decreased fast AHP without affecting medium AHP. Finally, blockade of BK channels decreased spike frequency in response to current injection in both control and NMDM without reducing the difference of spike frequency between the two groups. Therefore, we conclude that although BK transient outward currents, which may alter AP repolarization, are increased in NMDM, BK channels do not directly contribute to maternal diabetes-induced attenuation of PCMN excitability. In contrast, based on evidence from our previous and present studies, reduction of PCMN excitability in neonates of diabetic mothers is largely dependent on altered SK current associated with maternal diabetes.
Biomolecular Science Center, Burnett School of Biomedical Sciences, College of Medicine, University of Central Florida, 4000 Central Florida Blvd., Orlando, FL 32816, USA.
Min
M
Lin
Jeff T
JT
Hatcher
Qing-Hui
QH
Chen
Robert D
RD
Wurster
Lihua
L
Li
Zixi Jack
ZJ
Cheng
D000200:Action Potentials / Q000187:drug effects; D000818:Animals; D000831:Animals, Newborn; D005260:Female; D006321:Heart / Q000294:innervation*; D051036:Large-Conductance Calcium-Activated Potassium Channels / Q000037:antagonists & inhibitors / Q000378:metabolism*; D008526:Medulla Oblongata / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D051379:Mice; D009046:Motor Neurons / Q000187:drug effects / Q000378:metabolism*; D010275:Parasympathetic Nervous System / Q000187:drug effects / Q000378:metabolism* / Q000503:physiopathology; D018408:Patch-Clamp Techniques; D026902:Potassium Channel Blockers / Q000494:pharmacology; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000378:metabolism* / Q000503:physiopathology; D011297:Prenatal Exposure Delayed Effects; D051640:Small-Conductance Calcium-Activated Potassium Channels / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors
D051036:Large-Conductance Calcium-Activated Potassium Channels; D026902:Potassium Channel Blockers; D051640:Small-Conductance Calcium-Activated Potassium Channels
Endocrinology. 1992 Mar;130(3):1387-93
1371447
J Physiol. 1987 Aug;389:187-203
2445972
J Neurophysiol. 2007 May;97(5):3314-30
17360829
Prog Neurobiol. 2002 Apr;66(5):345-53
12015199
J Physiol. 1999 Nov 15;521 Pt 1:135-46
10562340
J Neurophysiol. 1990 Jan;63(1):72-81
2299387
Curr Opin Chem Biol. 1999 Aug;3(4):448-58
10419851
J Gen Physiol. 1981 Jan;77(1):77-93
6259274
Nature. 1982 Apr 22;296(5859):746-9
6280066
J Physiol. 1996 Sep 1;495 ( Pt 2):353-66
8887749
Proc Natl Acad Sci U S A. 2004 Jun 22;101(25):9474-8
15194823
Proc Natl Acad Sci U S A. 1999 Apr 13;96(8):4662-7
10200319
Learn Mem. 1998 Sep-Oct;5(4-5):257-73
10454353
J Physiol. 1987 Jun;387:519-48
2443684
J Neurosci. 1996 Feb 1;16(3):955-63
8558264
J Comp Neurol. 2000 Sep 4;424(4):588-606
10931483
J Physiol. 1989 Feb;409:171-90
2585290
Am J Physiol Cell Physiol. 2010 Dec;299(6):C1285-98
20739619
Diabetes. 2002 Jan;51(1):174-81
11756338
Int J Dev Neurosci. 2007 Oct;25(6):349-57
17888615
Am J Physiol. 1996 Dec;271(6 Pt 2):H2609-14
8997322
J Neurophysiol. 2001 Aug;86(2):771-81
11495949
Auton Neurosci. 2010 Jan 15;152(1-2):67-74
19910264
J Physiol. 1988 May;399:191-205
3404462
Auton Neurosci. 2010 Jun 24;155(1-2):39-48
20171940
Cell. 1989 Sep 22;58(6):1067-73
2673540
Am J Physiol Regul Integr Comp Physiol. 2005 May;288(5):R1129-33
15661971
Diabetes. 2004 Dec;53(12):3248-57
15561957
J Neurophysiol. 1992 Nov;68(5):1834-41
1336045
J Physiol. 2003 Apr 1;548(Pt 1):53-69
12576503
J Physiol. 2007 May 1;580(Pt.3):859-82
17303637
J Neurophysiol. 1988 Feb;59(2):424-49
3351569
J Physiol. 1987 Apr;385:733-59
2443676
J Neurosci. 2001 Feb 15;21(4):1385-92
11160410
J Neurosci. 1996 Jul 1;16(13):4089-101
8753871
Cardiovasc Diabetol. 2005 Oct 01;4:15
16197556
Am J Physiol Regul Integr Comp Physiol. 2004 Apr;286(4):R625-33
14644755
Nat Neurosci. 2005 Dec;8(12):1752-9
16261134
Neuropharmacology. 1996;35(7):963-8
8938726
Eur J Epidemiol. 1992 Jul;8(4):503-8
1397216
J Neurosci. 2002 Mar 1;22(5):1618-28
11880492
Trends Neurosci. 1996 Apr;19(4):150-4
8658599
Trends Neurosci. 1989 Feb;12(2):59-65
2469212
J Physiol. 2002 Dec 15;545(3):945-60
12482898
Neuropharmacology. 1996;35(7):903-14
8938721
Neuroscience. 2008 Mar 27;152(3):741-52
18328631
J Biol Chem. 1990 Nov 5;265(31):18745-8
1699936
Exp Neurol. 2009 Nov;220(1):34-43
19615367
J Neurophysiol. 2010 Oct;104(4):2125-38
20668269
Curr Med Chem. 2009;16(18):2345-54
19519395
J Comp Neurol. 2010 Jul 15;518(14):2771-93
20506475
Nat Rev Neurosci. 2004 Oct;5(10):758-70
15378036
Diabetes Care. 1998 Aug;21 Suppl 2:B156-60
9704244
Neuroscientist. 2003 Jun;9(3):181-94
15065814